Elanco Animal Health has faced revenue declines and suffered from high debt, creating a challenging operating environment. The company's performance has been disappointing, with missed synergy targets ...

Elanco Animal Health's stock declined 26%, but despite improved financials, high debt levels and limited growth opportunities make it a cautious investment. Fiscal 2024 saw slight revenue growth and a ...

Elanco Animal Health (NYSE:ELAN) is at a 52-week high after the company’s first-quarter earnings release. Not only did the animal health company beat consensus expectations, but it also provided ...

Phibro Animal Health Corporation PAHC is well-positioned to grow in the coming quarters due to the ongoing momentum of its Animal Health business. The company’s operations in nearly 90 countries ...

Phibro Animal Health PAHC shares have climbed 52.8% in a year, showcasing impressive momentum. The stock has outpaced the industry’s 14.3% growth and the S&P 500 composite’s 11.7% gain. With healthy ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX ...

Zoetis Inc (NYSE:ZTS) tumbled to a 52-week low after a media report suggested the company’s arthritis shots, Librela and Solensia, could have sickened dogs and cats. Solensia (frunevetmab) gained FDA ...